Discover 2,726 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,726
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: New Haven CT, White Plains NY, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase 3, Recruiting
Active & Responsive
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for
Urothelial Carcinoma
Location: New York NY, Toronto, Pittsburgh PA, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05562830
Phase 1, Phase 2, Recruiting
Active & Responsive
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
for
High-Risk Neuroblastoma
Location: The Bronx NY, Philadelphia PA, Durham NC, Toronto,
Sponsor: Renaissance Pharma Ltd.
Sex: All
Age: 1 - 18
Code: NCT07549321
Phase 2, Phase 3, Recruiting
Active & Responsive
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
for
Myotonic Dystrophy 1
Location: Saguenay, Ottawa, Calgary
Sponsor: PepGen Inc
Sex: All
Age: 0+
Code: NCT07220603
Phase 2, Recruiting
Active & Responsive
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
for
Malignant Neoplasm
Location: Quebec, New Brunswick NJ, Montreal, Fairfax VA, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07247110
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
tDCS as Treatment for Motor Function
for
Progressive Supranuclear Palsy,
Location: Toronto
Sponsor: Baycrest
Sex: All
Age: 0+
Code: NCT07291687
Recruiting
Active & Responsive
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
for
Obesity or Overweight, Weight-Related Comorbidity,
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
for
Hypercholesterolaemia
Location: Sherbrooke, Millville NJ, Stouffville,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07619131
Phase 3, Recruiting
Active & Responsive
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
for
Uveal Melanoma
Location: Philadelphia PA, Toronto, Nashville TN, Scottsdale AZ
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07804186
Phase 3, Recruiting
Active & Responsive
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
for
Achondroplasia
Location: Montreal, Baltimore MD, Ottawa, Madison WI, Oakland CA
Sponsor: QED Therapeutics, a BridgeBio company
Sex: All
Age: 0 - 2
Code: NCT07169279
Phase 2, Recruiting
Active & Responsive
Magnetic Seizure Therapy for Schizophrenia - Trial
for
Treatment Resistant Schizophrenia, Schizophrenia,
Location: Toronto, Vancouver
Sponsor: Centre for Addiction and Mental Health
Sex: All
Age: 18+
Code: NCT06672588
Recruiting
Active & Responsive
Piloting a Brief, Online Intervention for Suicidality in Sexual and Gender Minority Youth
for
Suicidal Thoughts, Sexual and Gender Minorities, Youth
Location: London
Sponsor: Western University
Sex: All
Age: 13 - 25
Code: NCT07402265
Recruiting
Active & Responsive
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
for
Huntington Disease
Location: Toronto, Englewood CO
Sponsor: Skyhawk Therapeutics, Inc.
Sex: All
Age: 25+
Code: NCT07378644
Phase 2, Phase 3, Recruiting
Active & Responsive
Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis
for
Colorectal Adenocarcinoma Metastatic in the Liver,